Filsuvez 100 mg/g
As listed in the register: Filsuvez 100 mg/g, Gel
100 mg/g ·
- Prescription only
- Skin
- Active substance
- Betulae corticis extractum siccum raffinatum (Betula pendula Roth + Betula pubescens Ehrh. und deren Hybride + Cortex)
- Used in
- Skin
- Made by
- Chiesi SA
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
- Filsuvez est utilisé pour le traitement des plaies peu profondes associées à l’épidermolyse bulleuse (EB) dystrophique et jonctionnelle chez les patients dès l’âge de 6 mois.
From the official label · 2026-09-30 · Swissmedic
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
European UnionNo exact match for this strength and form
SpainNo exact match for this strength and form
NetherlandsNo exact match for this strength and form
Details
| Made by | Chiesi SA |
|---|---|
| Active substance | Betulae corticis extractum siccum raffinatum (Betula pendula Roth + Betula pubescens Ehrh. und deren Hybride + Cortex) |
| Used in | Skin |
| Strength | 100 mg/g |
| Classification | D03AX13 · Skin |
| Dispensing (as stated by the register) | Abgabekategorie B |
| Name in the register | Filsuvez 100 mg/g, Gel |
| Packs | 10 Einzeldose(n) · 30 Einzeldose(n) |
| Zulassungsnummer | 70069 |
| Dosisstärke | 1 |
Source: Zugelassene Packungen Humanarzneimittel · 2026-09-30 · not reviewed by a clinician
Quelle: Swissmedic. The publisher’s terms do not grant reproduction, so text is shortened and linked. Publisher’s terms.